journal of men's health
Volume 5, Issue 4 , Pages 289-296 , December 2008

Erectile dysfunction, testosterone deficiency, metabolic syndrome and prostatic disease in Taiwan

Received 23 July 2008 ,Accepted 21 October 2008.

References 

  1. Tan HM, Low WY, Ng CJ, Chen KK, Sugita M, Ishii N, et al. Prevalence and correlates of erectile dysfunction (ED) and treatment seeking for ED in Asian Men: the Asian Men's Attitudes to Life Events and Sexuality (MALES) study. J Sex Med. 2007;4(6):1582–1592
  2. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44(6):637–649
  3. Hwang TI, Lo HC, Tsai TF, Chiou HY. Association among hypogonadism, quality of life and erectile dysfunction in middle-aged and aged male in Taiwan. Int J Impot Res. 2007;19(1):69–75
  4. Chen KK, Chiang HS, Jiann BP, Lin JS, Liu WJ, Wu CJ, et al. Prevalence of erectile dysfunction and impacts on sexual activity and self-reported intercourse satisfaction in men older than 40 years in Taiwan. Int J Impot Res. 2004;16(3):249–255
  5. Wu CJ, Hsieh JT, Lin JS, Hwang TI, Jiann BP, Huang ST, et al. Comparison of prevalence between self-reported erectile dysfunction and erectile dysfunction as defined by five-item International Index of Erectile Function in Taiwanese men older than 40 years. Urology. 2007;69(4):743–747
  6. Jiann BP. Sexual dysfunction in men who abuse illicit drugs: a preliminary report. J Sex Med 2007 [E-pub 18 Dec 2007].
  7. Hsieh FI, Hwang TS, Hsieh YC, Lo HC, Su CT, Hsu HS, et al. Risk of erectile dysfunction induced by arsenic exposure through well water consumption in Taiwan. Environ Health Perspect. 2008;116(4):532–536
  8. Chen KK, Hsieh JT, Huang ST, Jiaan DB, Lin JS, Wang CJ, et al. ASSESS-3: a randomised, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction in Taiwan. Int J Impot Res. 2001;13(4):221–229
  9. Jiann BP, Yu CC, Tsai JY, Wu TT, Lee YH, Huang JK. What to learn about sildenafil in the treatment of erectile dysfunction from 3-year clinical experience. Int J Impot Res. 2003;15(6):412–417
  10. Chen KK, Jiann BP, Lin JS, Lee SS, Huang ST, Wang CJ, et al. Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: a randomized, double-blind, parallel, placebo-controlled clinical study. J Sex Med. 2004;1(2):201–208
  11. Chen KK, Paick JS, Ishii N Vardenafil Study Group. The efficacy and safety of vardenafil in East Asian men with erectile dysfunction. J Sex Med. 2007;4(3):753–761
  12. Jiann BP, Yu CC, Su CC, Huang JK. Rechallenge prior sildenafil nonresponders. Int J Impot Res. 2004;16(1):64–68
  13. Jiann BP, Yu CC, Su CC, Tsai JY. Compliance of sildenafil treatment for erectile dysfunction and factors affecting it. Int J Impot Res. 2006;18(2):146–149
  14. Jiann BP, Yu CC, Su CC. Impact of introduction of sildenafil on other treatment modalities for erectile dysfunction: a study of nationwide and local hospital sales. Int J Impot Res. 2004;16(6):527–530
  15. Tsai YS, Lin JS, Lin YM. Safety and efficacy of alprostadil sterile powder (S. Po., CAVERJECT) in diabetic patients with erectile dysfunction.. Eur Urol. 2000;38(2):177–183
  16. Chiang HS, Wen TC, Liang JF. Titration study of MUSE (Medicated Urethral System for Erection) in erectile dysfunction. J Formos Med Assoc. 2000;99(12):926–930
  17. Chiang HS, Wu CC, Wen TC. 10 years of experience with penile prosthesis implantation in Taiwanese patients. J Urol. 2000;163(2):476–480
  18. Wen HS, Hsieh CH, Hsu GL, Kao YC, Ling PY, Huang HM, et al. The synergism of penile venous surgery and oral sildenafil in treating patients with erectile dysfunction. Int J Androl. 2005;28(5):297–303
  19. Schneider HJ, Sievers C, Klotsche J, Böhler S, Pittrow D, Lehnert H, et al. Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study. Clin Endocrinol (Oxf) 2008 [E-pub 7 Aug 2008].
  20. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762–769
  21. Wu CY, Yu TJ, Chen MJ. Age related testosterone level changes and male andropause syndrome. Chang Gung Med J. 2000;23(6):348–353
  22. Lin YC, Hwang TI, Chiang HS, Yang CR, Wu HC, Wu TL, et al. Correlations of androgen deficiency with clinical symptoms in Taiwanese males. Int J Impot Res. 2006;18(4):343–347
  23. Hwang TI, Juang GD, Yeh CH, Chang YH, Chou KY, Chen HE. Hormone levels in middle-aged and elderly men with and without erectile dysfunction in Taiwan. Int J Impot Res. 2006;18(2):160–163
  24. Chiang HS, Hwang TI, Hsui YS, Lin YC, Chen HE, Chen GC, et al. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function. Int J Impot Res. 2007;19(4):411–417
  25. Hwang TI, Chen HE, Tsai TF, Lin YC. Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone. Int J Impot Res. 2006;18(4):400–404
  26. Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc. 2006;105(8):626–635
  27. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community. Atherosclerosis. 2007;194(1):214–221
  28. Lin CC, Liu CS, Lai MM, Li CI, Chen CC, Chang PC, et al. Metabolic syndrome in a Taiwanese metropolitan adult population. BMC Public Health. 2007;7(147):239
  29. Lai SW, Liao KF, Li TC, Lin HF, Lin WY, Lin CH. Metabolic syndrome in older people in Taiwan: a hospital-based study. Intern Med J. 2006;36(10):648–651
  30. Huang KC, Lee LT, Chen CY, Sung PK. All-cause and cardiovascular disease mortality increased with metabolic syndrome in Taiwanese. Obesity (Silver Spring). 2008;16(3):684–689
  31. Hsu PF, Chuang SY, Cheng HM, Tsai ST, Chou P, Chen CH. Clinical significance of the metabolic syndrome in the absence of established hypertension and diabetes: a community-based study. Diabetes Res Clin Pract. 2008;79(3):461–467
  32. Tang YJ, Lee WJ, Chen YT, Liu PH, Lee MC, Sheu WH. Serum testosterone level and related metabolic factors in men over 70 years old. J Endocrinol Invest. 2007;30(6):451–458
  33. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab. 2006;91(3):843–850
  34. Yeh HC, Wang CJ, Lee YC, Hsiao HL, Wu WJ, Chou YH, et al. Association among metabolic syndrome, testosterone level and severity of erectile dysfunction. Kaohsiung J Med Sci. 2008;24(5):240–247
  35. Kupelian V, Shabsigh R, Araujo AB, O’Donnell AB, McKinlay JB. Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study. J Urol. 2006;176(1):222–226
  36. Ozden C, Ozdal OL, Urgancioglu G, Koyuncu H, Gokkaya S, Memis A. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol. 2007;51(1):199–203discussion 204–6
  37. Yu HJ, Chiang GJ, Chie WC, Chiu TY, Lai MK. Prevalence of urinary symptoms in men aged 40 to 79 years -a community study. J Urol ROC. 1995;6:7–12
  38. Yu HJ, Chen TH, Chie WC, Liu CY, Tung TH, Huang SW. Prevalence and associated factors of nocturia among adult residents of the Matsu area of Taiwan. J Formos Med Assoc. 2005;104(6):444–447
  39. Huang WJ, Chen KK, Chang LS. Correlation between voiding and erectile function in patients with symptomatic benign prostatic hyperplasia. J Chin Med Assoc. 2005;68(4):178–182
  40. Liu CC, Huang SP, Li WM, Wang CJ, Wu WJ, Chou YH, et al. Are lower urinary tract symptoms associated with erectile dysfunction in aging males of Taiwan?. Urol Int. 2006;77(3):251–254
  41. Liu CC, Huang SP, Li WM, Wang CJ, Chou YH, Li CC, et al. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men. Urology. 2007;70(4):677–680
  42. Pu YS. Prostate cancer in Taiwan: epidemiology and risk factors. Int J Androl. 2000;23(Suppl 2):34
  43. National Cancer Registry. Annual Report of Taiwan Cancer Registry. Available at: http://crs.cph.ntu.edu.tw/crs_c/annual.html. (Accessed June 2007).
  44. Wu TT, Huang JK. Annual changes in the clinical features of prostatic adenocarcinoma in Taiwan. BJU Int. 2001;87(1):57–60
  45. Wong WY, Chen SC, Chueh SC, Chen J. The trend of managing prostate cancer in Taiwan. Int J Urol. 2004;11(7):510–514
  46. Chen CH, Tzai TS, Huang SP, Wu HC, Tai HC, Chang YH, et al. Clinical outcome of Taiwanese men with metastatic prostate cancer compared with other ethnic groups. Urology 2008 [E-pub 25 March 2008].
  47. Murphy GP, Natarajan N, Pontes JE, Schmitz RL, Smart CR, Schmidt JD, et al. The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol. 1982;127:928–934

PII: S1875-6867(08)00213-3

doi: 10.1016/j.jomh.2008.10.007

journal of men's health
Volume 5, Issue 4 , Pages 289-296 , December 2008

Article Tools

* Image Usage & Resolution